Pfizer (PFE) Ticks Higher; Prevenar 13 Met Primary Objective

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. UNH
7. CVS
8. SBUX
9. AXP
10. ZETA

Go back to Pfizer (PFE) Ticks Higher; Prevenar 13 Met Primary Objective

Pfizer (PFE) Announces Top-Line Results Of Prevenar 13 Phase 3 Trial

October 4, 2012 8:16 AM EDT

Pfizer Inc. (NYSE: PFE) today announced top-line data assessing immunogenicity, tolerability and safety of Prevenar 13®* (Pneumococcal polysaccharide conjugate vaccine [13-valent, absorbed]) in adults 18 to 49 years of age. These data support a recent regulatory submission to expand the indication of Prevenar 13 in the European Union to... More